NSUN5 and glioblastoma: Our results indicate that NSUN5 methylates cytosine 3782 of 28S rRNA, and promotes protein synthesis and tumorigenic phenotypes in GBM, suggesting that NSUN5 is a potential therapeutic target for GBM.